MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2.
about
Dysregulated miR-27a-3p promotes nasopharyngeal carcinoma cell proliferation and migration by targeting Mapk10.MiR-27a rs895819 is involved in increased atrophic gastritis risk, improved gastric cancer prognosis and negative interaction with Helicobacter pylori.MicroRNA-27a contributes to the malignant behavior of gastric cancer cells by directly targeting PH domain and leucine-rich repeat protein phosphatase 2.Knockdown of miR-27a sensitizes colorectal cancer stem cells to TRAIL by promoting the formation of Apaf-1-caspase-9 complex.Association of two microRNA polymorphisms miR-27 rs895819 and miR-423 rs6505162 with the risk of cancer.Distinct effects of rs895819 on risk of different cancers: an update meta-analysis.MicroRNA-27a regulates hepatic lipid metabolism and alleviates NAFLD via repressing FAS and SCD1.miR-27a-3p targeting RXRα promotes colorectal cancer progression by activating Wnt/β-catenin pathway.MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.The miR-17/92 cluster is involved in the molecular etiology of the SCLL syndrome driven by the BCR-FGFR1 chimeric kinase.PRMT5 promotes cell proliferation by inhibiting BTG2 expression via the ERK signaling pathway in hepatocellular carcinoma.Inhibition of TNFα-interacting protein α (Tipα)-associated gastric carcinogenesis by BTG2/TIS21 via downregulating cytoplasmic nucleolin expression.Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma.MicroRNA-539 inhibits colorectal cancer progression by directly targeting SOX4.MicroRNA-23a/27a/24-2 cluster promotes gastric cancer cell proliferation synergistically.
P2860
Q33671062-FDBC9018-39AA-480A-BF53-EF91BDC808DBQ37620509-15259685-200B-49AA-8A7B-2C363FCFE37FQ37715728-C30BE9D2-CD25-49BD-ADEA-61A0E898185CQ41233246-A6C27AE3-85A0-468F-AA6D-A73B2FBE3B34Q41470849-91F8F1FA-886E-4243-98CE-0D512F52CB92Q43925584-DA4B27DA-2BE0-489E-AFF1-8673D0D22757Q44303902-2FBD69CF-E50C-43BD-9E34-A6EC450B8309Q47168497-BEBDCC12-76BB-46BE-96D2-00AEC6FB5319Q49275839-EA9A92D4-0202-48F3-83DB-0883AD7C2C4FQ49723864-F12961F8-9A8F-4FF5-A5FE-FADA569D77A0Q50019708-5EABFCF5-35B8-4656-8138-C56064A7A2ECQ52689090-9744E91D-A945-48F8-808A-2A4D7D39265BQ55418427-66545C48-E471-4DCC-BAF5-9B94AB3AB0B1Q55665136-430C8426-3E47-48C7-937C-A2A659E9972FQ55711744-C42D30D1-EBCC-49E7-AC66-0F9805A6A4D3
P2860
MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2.
@en
MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2.
@nl
type
label
MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2.
@en
MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2.
@nl
prefLabel
MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2.
@en
MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2.
@nl
P2093
P2860
P356
P1433
P1476
MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2.
@en
P2093
Guoxiang Cai
Hongkun Wu
Jianwen Liu
Lingling Zhang
Liyan Yang
Norio Nagao
Shengchao Lin
P2860
P304
51943-51954
P356
10.18632/ONCOTARGET.10460
P407
P577
2016-07-07T00:00:00Z